AbbVie accounted for 16.38% of the cytokines revenue market share in 2015. AbbVie, Johnson & Johnson, GlaxoSmithKline, Novartis and Roche are the key players and accounted for over 39.63% of the overall insect repellent market share in 2015.
Global giant manufactures mainly distributed in North America and Europe. They have unshakable status in this field. North America takes the revenue market share of 41.82% in 2015, Europe followed by with 30.69% in 2015. Particularly, there is hardly a large enterprise and market is very fragmented.
The market is not only influenced by the price, but also influenced by the product performance. The leading companies own the advantages on better performance, more abundant product’s types, better technical.
Looking to the future years, prices gap between different brands will go narrowing. Similarly, there will be fluctuation in gross margin.
Despite the presence of competition problems, due to the global recovery trend is slightly, investors are still optimistic about this area; the future will still have more new investment enter the field.
The global Cytokines market is valued at 119000 million US$ in 2018 is expected to reach 401000 million US$ by the end of 2025, growing at a CAGR of 16.4% during 2019-2025.
This report focuses on Cytokines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cytokines market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Johnson & Johnson
Bayer HealthCare Pharmaceuticals
Thermo Fisher Scientific
Segment by Regions
Segment by Type
Segment by Application
Cancer and Malignancy
Asthma / Airway Inflammation